Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pramod Avti, Arushi Chauhan, Nishant Shekhar, Manisha Prajapat, Phulen Sarma, Hardeep Kaur, Anusuya Bhattacharyya, Subodh Kumar, Ajay Prakash, Saurabh Sharma & Bikash Medhi. (2022) Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings. Journal of Biomolecular Structure and Dynamics 40:19, pages 8894-8904.
Read now
Read now
Khurram Jamil, Stephen Chris Pappas & Krishna R Devarakonda. (2018) In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2. Journal of Experimental Pharmacology 10, pages 1-7.
Read now
Read now
Articles from other publishers (23)
Yong He, Lu Chai, Han Chen & Xing-Shun Qi. (2023) Effect of different infusion approaches on safety and efficacy of terlipressin: Current controversies. World Chinese Journal of Digestology 31:17, pages 705-710.
Crossref
Crossref
Marcelo Rodrigues Cunha, Daniel Reis Waisberg, Lucas Ernani, Michel Ribeiro Fernandes, Pedro Batista Pereira, Rafael Soares Pinheiro, Lucas Souto Nacif, Vinicius Rocha-Santos, Rodrigo Bronze Martino, Liliana Ducatti, Rubens Macedo Arantes, Flávio Henrique Galvão, Eduardo Guimarães De Moura, Luiz Augusto Carneiro-D'albuquerque & Wellington Andraus. (2022) Duodenal Necrosis and Nonvariceal Digestive Bleeding After Terlipressin Administration for Treatment of Hepatorenal Syndrome: a Case Report of a Novel Side Effect of a Commonly Used Drug. Transplantation Proceedings 54:5, pages 1391-1393.
Crossref
Crossref
Mladena Glavaš, Agata Gitlin-Domagalska, Dawid Dębowski, Natalia Ptaszyńska, Anna Łęgowska & Krzysztof Rolka. (2022) Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides. International Journal of Molecular Sciences 23:6, pages 3068.
Crossref
Crossref
Sheeba Khan, Owen Cain & Neil Rajoriya. 2022. Men’s Health and Wellbeing. Men’s Health and Wellbeing
163
191
.
Anand V. Kulkarni, Juan Pablo Arab, Madhumita Premkumar, Carlos Benítez, Sowmya Tirumalige Ravikumar, Pramod Kumar, Mithun Sharma, Duvvuru Nageshwar Reddy, Douglas A. Simonetto & Padaki Nagaraja Rao. (2020) Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Liver International 40:12, pages 2888-2905.
Crossref
Crossref
Xiao-Long Li, Xiao-Dong Zhu, Nan Xiao, Xue-Feng Liu, Bin Xu, Guo-Ming Shi, Cheng Huang, Ying-Hao Shen, Jia-Bin Cai, Jian Zhou, Jia Fan & Hui-Chuan Sun. (2020) A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study. Surgery 167:6, pages 926-932.
Crossref
Crossref
Xiaofeng Pan, Ziye Zhou, Xiangxiang Jin & Dawei Shi. (2019) Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin. Journal of Clinical Pharmacy and Therapeutics 45:1, pages 191-198.
Crossref
Crossref
Alberto Zanetto & Guadalupe Garcia-Tsao. 2020. The Critically Ill Cirrhotic Patient. The Critically Ill Cirrhotic Patient
39
66
.
Florence Wong. 2018. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
262
280.e5
.
Mohamed A. Kandil, Khalid M. Abouelenain, Ayman Alsebaey, Hanaa S. Rashed, Mohamed H. Afifi, Mohamed A. Mahmoud & Khaled A. Yassen. (2017) Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase‐associated lipocalin serum levels: A randomized controlled trial. Clinical Transplantation 31:8.
Crossref
Crossref
Martin Šíma, Miroslav Pokorný, František Paďour & Ondřej Slanař. (2016) Terlipressin Induced Severe Hyponatremia. Prague Medical Report 117:1, pages 68-72.
Crossref
Crossref
Florence Wong. 2015. Cirrhosis: A practical guide to management. Cirrhosis: A practical guide to management
175
188
.
Victor Gueutin, Aimele Meftah, Geoffroy Desbuissons, Lamis Debchi, Anne-Lyse Langlois, Nathalie Shehwaro & Hassane Izzedine. (2013) Le syndrome hépatorénal : mise au point. Néphrologie & Thérapeutique 9:7, pages 471-480.
Crossref
Crossref
Ayman Alsebaey, Wael Abdel-Razek, Ashraf Bassuni, Eman Rewisha, Magdy Khalil & Imam Waked. (2013) Prevention of paracentesis-induced circulatory dysfunction. Egyptian Liver Journal 3:4, pages 118-125.
Crossref
Crossref
Anna V. Kutina, Anna S. Marina, Ivan I. Eliseev, Mikhail I. Titov & Yuri V. Natochin. (2013) Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats. Journal of Peptide Science 19:5, pages 268-276.
Crossref
Crossref
Anna Kwiatkowska, Monika Lewandowska, Lenka Borovičková, Jiřina Slaninová, Bernard Lammek & Adam Prahl. (2013) Design, Synthesis and Structure-Activity Relationship of New Arginine Vasopressin Analogues Containing Proline Derivatives in Position 2. Chemical Biology & Drug Design 81:3, pages 420-428.
Crossref
Crossref
Matthias Hinz, Alexander Wree, Christoph Jochum, Lars P. Bechmann, Fuat Saner, Alexander L. Gerbes, Guido Gerken & A.l.i. Canbay. (2013) High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome. Annals of Hepatology 12:1, pages 92-99.
Crossref
Crossref
Florence Wong. (2012) Recent advances in our understanding of hepatorenal syndrome. Nature Reviews Gastroenterology & Hepatology 9:7, pages 382-391.
Crossref
Crossref
Georgios N. Kalambokis, Konstantinos Pappas & Epameinondas V. Tsianos. (2011) Differential Effects of Terlipressin on Pulmonary and Systemic Hemodynamics in Patients With Cirrhosis and Pulmonary Hypertension. Angiology 63:3, pages 199-205.
Crossref
Crossref
Basilio Fimiani, Domenico Della Guardia, Claudio Puoti, Giuseppe D' Adamo, Olimpia Cioffi, Anna Pagano, Maria Rosaria Tagliamonte & Antonio Izzi. (2011) The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: A multicentric study. European Journal of Internal Medicine 22:6, pages 587-590.
Crossref
Crossref
George Kalambokis, Spyridon Tsiouris, Epameinondas V. Tsianos, Gerasimos Baltayiannis, Barbara Pakou & Andreas Fotopoulos. (2010) Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis. Liver International 30:9, pages 1371-1378.
Crossref
Crossref
Sashidhar V Sagi, Sahil Mittal, Krishna S Kasturi & Gagan K Sood. (2010) Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-analysis of randomized controlled trials. Journal of Gastroenterology and Hepatology 25:5, pages 880-885.
Crossref
Crossref
Dietrich Hasper & Thomas Berg. 2010. Management of Acute Kidney Problems. Management of Acute Kidney Problems
297
304
.